The results showed that in TRIM67-upregulated tumors, the integrated breast cancer pathway was upregulated, whereas the miRNA targets in ECM and membrane receptors and miRNAs involved in DNA damage response pathways were downregulated (Figure 6C). This evidence concerns the gene TRIM67 and breast carcinoma.